Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia.
about
Diagnosis and subclassification of acute lymphoblastic leukemiaCurrent concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemiaCIViC databasePrognostification of ALL by CytogeneticsThe 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2AProphylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation.Somatic drivers of B-ALL in a model of ETV6-RUNX1; Pax5(+/-) leukemia.Function of Ikaros as a tumor suppressor in B cell acute lymphoblastic leukemiaSynergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia.Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features.What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia.Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL study.Genomic characterization of acute leukemias.Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia.Towards an understanding of the biology and targeted treatment of paediatric relapsed acute lymphoblastic leukaemia.Conserved IKAROS-regulated genes associated with B-progenitor acute lymphoblastic leukemia outcome.Mechanism of ETV6-RUNX1 Leukemia.Ikaros: Exploiting and targeting the hematopoietic stem cell niche in B-progenitor acute lymphoblastic leukemia.Transcriptome Analysis of Minimal Residual Disease in Subtypes of Pediatric B Cell Acute Lymphoblastic Leukemia.Changing of IKZF1 genotype during Philadelphia-negative precursor-B acute lymphoblastic leukemia progression: a short clinical report.A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia.Recent advances in the management of pediatric acute lymphoblastic leukemia.Copy number profiling of adult relapsed B-cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanisms.TP53 in adult acute lymphoblastic leukemia.Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor.Prognostic impact of RUNX1 and ETV6 gene copy number on pediatric B-cell precursor acute lymphoblastic leukemia with or without hyperdiploidy.Possible implication of IKAROS gene deletion and BCR-ABL1 variants in progression of chronic myeloid leukemia to lymphoid blast crisis in childhood: a single-institution experience.Childhood relapsed acute lymphoblastic leukemia: Biology and recent treatment progress.Prognostic significance of copy number alterations detected by multi-link probe amplification of multiple genes in adult acute lymphoblastic leukemia.Intragenic amplification of : a novel subgroup in B-cell precursor acute lymphoblastic leukemia?
P2860
Q26824387-6BA945E5-5F6E-46EF-9D82-0514874FCDEAQ27025242-7ADE8F40-0083-412E-B566-1FC2A331B017Q27612411-65980332-8708-4479-996C-844FBDF2F309Q28087446-D4F73B76-D4F2-4097-9C2F-DEF319C3F396Q28391081-E23FFAB8-4FDF-4E2A-9BE0-CC81F777EA8AQ35100974-B8693CE4-1435-41E1-B5EB-9A9D0FD5937BQ35744654-A25E9D74-D6AC-44DF-BD2B-F747A5F824AFQ36562871-784213C9-99CA-4AAF-95FF-54C4335C6F66Q36591877-AE7D5904-0ED9-411D-80BF-0A9404BC8C4EQ36967133-1D2DA4E0-1468-4A53-89E5-4530A703BA04Q37060647-77B4C2BC-2A12-4BD0-8614-F0DF47DF483FQ37262456-0A65833E-166A-4558-81CE-23FD4F2CA49CQ37575938-458F01F2-6C08-4320-AAF8-D268F365EDBEQ38223490-9A170F01-BACF-4609-8C5B-FDB63D63832FQ38492313-7A4187FD-475A-4E5D-8EE0-470B58176C72Q38633437-DF4F3BE3-4B27-4561-9B48-E58D1652F5DEQ38716763-E5602EF7-CE91-4E52-8430-094537947C4DQ38744459-A45540E1-6819-477C-A86B-938F76A58CD3Q39014321-2598E3F0-F172-48DD-9986-5D6932DC75E7Q41090525-78E53858-CA80-4DA4-AF3B-8DA70E038A38Q41874989-BA602092-19C0-4EA7-A80A-6C42CD66B5AEQ42360020-09A0D48D-50EF-4920-8B60-BFE423B02B4EQ45105040-2B98243F-F46C-4803-B3DE-FA559A4E92E1Q48323019-B605EBA1-02B2-4744-B51D-966A8ECE2319Q50906605-39836731-429A-4B11-AD0E-14282B84D791Q51026411-83E77A88-1D8D-47EA-83AA-26D61926E489Q51653753-BCDC942A-FCC6-4B8C-B070-E746F0984542Q53224137-00C89CDF-CC8D-4B61-943F-27054CBFF767Q53814000-87120893-93DC-4B04-A530-9247B670ED09Q54120651-0953162F-680F-49DF-B360-74FF8ACE3649Q57093827-A77EBD49-0F90-4EE5-9D3B-0058D482C68C
P2860
Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Prognostic value of genetic al ...... acute lymphoblastic leukemia.
@ast
Prognostic value of genetic al ...... acute lymphoblastic leukemia.
@en
Prognostic value of genetic al ...... acute lymphoblastic leukemia.
@nl
type
label
Prognostic value of genetic al ...... acute lymphoblastic leukemia.
@ast
Prognostic value of genetic al ...... acute lymphoblastic leukemia.
@en
Prognostic value of genetic al ...... acute lymphoblastic leukemia.
@nl
prefLabel
Prognostic value of genetic al ...... acute lymphoblastic leukemia.
@ast
Prognostic value of genetic al ...... acute lymphoblastic leukemia.
@en
Prognostic value of genetic al ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P3181
P356
P1433
P1476
Prognostic value of genetic al ...... acute lymphoblastic leukemia.
@en
P2093
A Mendioroz
A von Stackelberg
C Hagemeier
J C Engelmann
P2860
P2888
P304
P3181
P356
10.1038/LEU.2012.155
P577
2013-02-01T00:00:00Z
P6179
1003932254